| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Alternative > Removing the Symptom of Disease |
|
Advice Pool - Removing the Symptom of Disease
The art of persuasion in medical matters is based on symptomology. - The patient describes a symptom to a practitioner. - T According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product he practitioner gives the symptom a name. - The practitioner prescribes a 'remedy' for the treatment of the symptom. - The ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in patient pays the bill, applies the remedy and watches and
waits - hoping for remediation of said symptom. - Sometimes the lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. symptom disappears. - Sometimes the symptom disappears and reappears in a different place. - Sometimes the symptom disappe here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe rs and an entirely different one
appears. The symptom is not the disease per se. The symptom is a response from a living o d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rganism that something is
'out of balance' within the organism. All diseases are 'conditions' of a living organism. A heal ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc thy organism displays conditions of vitality, happiness,
energy, mobility, flexibility etc. while a diseased condition will
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi display conditions contrary to these. All conditions of disease go through a process. They begin with; - Irritation - it nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ay be physical, chemical or
mental/electro-magnetic. Usually, an irritation is so slight that
it goes by unnoticed and is d and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ isregarded. If the irritation remains in effect, then the next stage of disease is; - Inflammation - with an associated bu ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ild up of heat. A good
illustration of this stage is a blister. If the irritation is not removed, the next stages of diseas ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e are; - Ulceration and hardening (other names incl; sclerosing and induration) After the 'callous' or hardening of the ti dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod sues has developed and
the 'irritation' still remains in effect, the next condition will
usually be termed cancerous. As y cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ou can see from this definition - a condition is not a
quiescent state of affairs but rather it is an active one, moving
fr tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen om one stage to another with accompanying changes in tissue
quality. The remedy in ALL conditions is to remove the cause(s) t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel - in this
explanation - to remove the irritation. Once the irritation has been removed, the living organism will proceed ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust o reverse its tendency and move toward a state or
condition of normalcy - health. YES! The body heals itself - provided tha y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products t it has enough latent
energy to complete its task - and of course - provided that the
condition has not proceeded toward i . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ts termination. I sincerely hope that you get the gist of the difference between 'symptomology' and 'conditionality' and p elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip roceed along your own
path with the least amount of irritation possible. All the best in living in your own harmony. Kevi tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Eliminate Risk in Real Estate Investment DirecTV 101: Basic Guide for Those Searching DirecTV Satellite Deals
|